HIF1A and chronic kidney disease: As shown in Figure 6A, the positive staining area of HIF-1α, a marker for hypoxia, in the CKD group was significantly larger than that in the Sham group, and losartan alleviated the expression of HIF-1α, which is consistent with the results of renal oxygenation evaluated by BOLD-MRI (Figure 4C).